You Searched For "GlaxoSmithkline Consumer Healthcare" and got 20 results
Sort By:
HUL shares are red hot as investors look past recent hiccups
The investors in India’s largest consumer staples company Hindustan Unilever (HUL) have recovered f…
Chandigarh NCLT nod for HUL, GlaxoSmithKline Consumer Healthcare merger deal
On December 3, 2018, Anglo-Dutch FMCG giant Unilever had announced the acquisition of health food …
PTI
Even if a successful coronavirus vaccine is developed, billions could struggle to access it because of a global shortage of glass vials
Vaccines are stored in glass vials, which are running low, slow to produce, and invariably the main…
Bill Bostock
EXCLUSIVE: The Chief Digital Officer at GSK tells us how traditional FMCG companies are adapting to a digitally evolving consumer base
"We see Digital medium a catalyst for marketing transformation. It offers a huge opportunity …
Hindustan Unilever and GlaxoSmithKline’s domestic consumer unit are merging in what is said to be India’s largest consumer goods deal ever
The businesses being divested, which include health drinks Horlicks, Maltova and Boost, brough…
Here’s why the Supreme Court has exempted Saridon from the ban on FDCs
A Supreme Court bench announced its decision while hearing a plea from drug manufacturers P…
Pharma giant GlaxoSmithKline signs mega deal with Pfizer that could change the face of global healthcare
"Ultimately, our goal is to create two exceptional, UK-based global companies, with appropriate cap…
Callum Burroughs
The 20 fastest-growing, highest-paying biotechs
These are Insider's biggest healthcare stories for June 21.
Lydia Ramsey Pflanzer
How to invest in healthcare, a massive market sector that offers unparalleled diversification for portfolios
The size and diversity of the healthcare sector make it a key industry for investors building a div…
Walecia Konrad
2018 was a big year for mergers and acquisitions in India. Here are the top deals
This year proved to be quite a robust one for mergers and acquisitions for Indian corporates. Bu…
The rise of Anne Wojcicki, the CEO of 23andMe who's about to be worth more than $1 billion when the genetic-testing giant makes its public debut
With Wojcicki gearing up to take 23andMe public, here's a look back at how she got her start and bu…
Avery Hartmans
Variants are threatening our vaccine progress
These are the top stories written by Business Insider's healthcare team for the week ending Februar…
Lydia Ramsey Pflanzer
More than 400,000 Excedrin bottles have been recalled because of holes in the bottles that could cause child poisoning
Certain bottles of the medication contain holes in the bottom that could be a risk for poisoning am…
Shoshy Ciment
The pandemic has shifted the focus towards tech and renewable energy — here are 10 promising sectors for investment, according to fund managers
As industries like hospitality and tourism decline, investors are putting their money into healthca…
Marc Shoffman
Dispensed: Medicare Advantage's surprising success, Nurx's rebound, and a new startup trying to upend how you get mental healthcare at work
Peter R. Orszag, Vice Chairman, Global Banking for Citigroup, Inc., speaks at… REUTERS 16/03/2011 0…
Lydia Ramsey
HUL fourth-quarter volume growth down 7%, profit falls 1%, India sales slide 9% — as COVID-19 strikes India’s largest consumer firm
Hindustan Unilever’s fourth-quarter earnings showed a 1% fall in profit after tax, a 9% fall in dom…
GE Healthcare just filed a confidential IPO, kickstarting a spinoff that would create one the world's biggest pharma giants
Germany's Siemens listed Healthineers unit in March, and its shares are up about 32% since, Bloombe…
Will Martin
Genetic testing could be the future of healthcare, but some doctors think companies like 23andMe might be doing more harm than good
Hazel reached this conclusion after reviewing the privacy policies and terms of service of nearly 1…
Erin Brodwin
Microsoft just named the most powerful woman in Big Pharma to its board. Here's everything you need to know about Emma Walmsley.
At the time, she was the first woman to head a major pharmaceutical company. She stated that she wa…
Clarrie Feinstein
HUL board to meet on April 1 to declare merger with GSKCH
"In this regard we further wish to inform you that in accordance with the terms of the scheme, a m…